HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NF 279

Also Known As:

8,8'-(carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino))bis(1,3,5-naphthalenetrisulfonic acid); NF-279; NF279

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Alvarez, Raymond: 1 article (01/2020)
2.	Chen, Benjamin K: 1 article (01/2020)
3.	Durham, Natasha D: 1 article (01/2020)
4.	Freeman, Tracey L: 1 article (01/2020)
5.	Hioe, Catarina E: 1 article (01/2020)
6.	Malik, Hagerah S: 1 article (01/2020)
7.	Patel, Foramben: 1 article (01/2020)
8.	Satija, Namita: 1 article (01/2020)
9.	Soare, Alexandra Y: 1 article (01/2020)
10.	Swartz, Talia H: 1 article (01/2020)

Related Diseases

1.

01/01/2020 - "NF279 and NF449 blocked productive infection at the level of viral membrane fusion, with a range of inhibitory activities against different HIV-1 Env isolates. "
01/01/2020 - "NF279 and NF449 interfered with the ability of the gp120 variable regions 1 and 2 (V1V2)-targeted broadly neutralizing antibody PG9 to block productive infection, suggesting that these drugs may antagonize HIV-1 Env at gp120 V1V2 to block viral membrane fusion. "

Related Drugs and Biologics

1.	Broadly Neutralizing Antibodies
2.	4,4,',4'',4'''- (carbonylbis(imino- 5,1,3- benzenetriylbis(carbonylimino)))tetrakis(benzene- 1,3- disulfonate)